Hsp90 inhibitor 17-AAG reduces ErbB2 levels and inhibits proliferation of the trastuzumab resistant breast tumor cell line JIMT-1
Barbara Zsebik, Ami Citri, Jorma Isola, Yosef Yarden, János Szöllosi, György Vereb*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
68Scopus
citations
Fingerprint
Dive into the research topics of 'Hsp90 inhibitor 17-AAG reduces ErbB2 levels and inhibits proliferation of the trastuzumab resistant breast tumor cell line JIMT-1'. Together they form a unique fingerprint.